August 2010 Briefing - Urology
Here are what the editors at HealthDay consider to be the most important developments in Urology for August 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Screening Guidelines Offered for Urinary Tract Conditions
MONDAY, Aug. 30 (HealthDay News) -- The American Urological Association (AUA) has published new guidelines for the screening of siblings and offspring of index patients with vesicoureteral reflux (VUR) and infants with prenatal hydronephrosis (PNH) in the September issue of The Journal of Urology.
PET/CT Imaging Restages Prostate Cancer After Surgery
FRIDAY, Aug. 27 (HealthDay News) -- Positron emission tomography/computerized tomography (PET/CT) to detect [11C]choline uptake appears to be useful for re-evaluating prostate cancer disease stage for men who have increasing prostate-specific antigen (PSA) levels after radical prostatectomy and no evidence of disease on conventional imaging, according to a study in the September issue of The Journal of Urology.
Surgery for Undescended Testes Often Occurs After Age 2
MONDAY, Aug. 23 (HealthDay News) -- Clinical guidelines recommend orchidopexy by age 1 for treatment of congenital undescended testes, but a substantial number of boys do not undergo the surgery even by age 2, according to research published online Aug. 23 in Pediatrics.
Prenatal DDT Exposure Tied to Testicular Cancer Risk
FRIDAY, Aug. 20 (HealthDay News) -- In the early postpartum period, maternal serum DDT-related compounds appear to be associated with sons' risk of testicular cancer three decades later, according to a study in the July issue of the Archives of Environmental & Occupational Health.
Ultrasound May Often Overestimate Renal Stone Size
THURSDAY, Aug. 19 (HealthDay News) -- Ultrasound often overestimates the size of stones in urolithiasis, particularly when the stones are 5 mm or smaller, according to research published in the August issue of Urology.
Urinary Incontinence Common in Women, Men, Children
THURSDAY, Aug. 19 (HealthDay News) -- Urinary incontinence (UI) is common -- more so in women than in men -- but exact prevalence is difficult to pinpoint due to variables in study methodology, definitions of UI, and populations studied, according to research published in the August issue of Urology.
Kidneys From Cardiac-Death, Brain-Dead Patients Equal
THURSDAY, Aug. 19 (HealthDay News) -- Kidneys transplanted from donors with controlled cardiac death perform as well as organs from brain-dead donors, according to research published online Aug. 19 in The Lancet.
Steroids in Cadaveric Donor Don't Benefit Kidney Recipient
WEDNESDAY, Aug. 18 (HealthDay News) -- Treating deceased kidney donors with corticosteroids in advance of kidney harvesting does not reduce the incidence or duration of acute renal failure (ARF) after transplantation in organ recipients, according to a study in the Aug. 17 issue of the Annals of Internal Medicine.
Totally Tubeless PCNL Effective, Safe in Elderly
WEDNESDAY, Aug. 18 (HealthDay News) -- Totally tubeless (tubeless and stentless) percutaneous nephrolithotomy (PCNL) is routinely used for adults with renal stones, and it appears to be safe, effective, and feasible even in elderly patients, according to research published in the August issue of Urology.
Finasteride Use Up in VHA System but Not for Prevention
TUESDAY, Aug. 10 (HealthDay News) -- Finasteride prescriptions in the Veterans Health Administration (VHA) increased between 2000 and 2005, but the increase probably was not due to doctors prescribing it for prostate cancer chemoprevention, according to research published online Aug. 10 in Cancer Epidemiology, Biomarkers & Prevention.
Gene Variants, High BMI Linked to Prostate Cancer Mortality
WEDNESDAY, Aug. 4 (HealthDay News) -- Several single nucleotide polymorphisms (SNPs) in the gene for fatty acid synthase (FASN) are associated with lethal prostate cancer, particularly among overweight men, according to a study published online Aug. 2 in the Journal of Clinical Oncology.
Industry-Funded Clinical Trials Yield More Positive Outcomes
TUESDAY, Aug. 3 (HealthDay News) -- Drug clinical trials supported by industry are more likely to produce favorable results than trials supported by government or nonprofit/nonfederal organizations, and they are less likely to be published within two years of the study being completed, according to research published in the Aug. 3 issue of the Annals of Internal Medicine.
Use of Some Common Drugs May Lower PSA Levels
TUESDAY, Aug. 3 (HealthDay News) -- The use of nonsteroidal anti-inflammatory drugs (NSAIDs), statins, or thiazide diuretics can significantly lower tested levels of prostate-specific antigen (PSA), according to research published online Aug. 2 in the Journal of Clinical Oncology.
Bladder Cancer Linked to Compounds in Processed Meat
MONDAY, Aug. 2 (HealthDay News) -- A diet high in certain compounds found in processed meats could put people at a slightly elevated risk for developing bladder cancer, according to research published online Aug. 2 in Cancer.